• PDF: Delivered by email usually within 4 to 8 UK business hours.

United States: Pharmaceuticals Industry Guide

  • Publication Date:March 2011
  • Publisher:Datamonitor
  • Product Type: Report
  • Pages:75

United States: Pharmaceuticals Industry Guide

Datamonitor's United States: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the United States Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Scope of the Report

  • Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
  • Provides textual analysis of the industry's prospects
  • Incorporates in-depth five forces competitive environment analysis and scorecards
  • Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals

Highlights

The US biotechnology market had total revenue of $71.2 billion in 2009, representing a compound annual growth rate (CAGR) of 8.2% for the period spanning 2005-2009.

The US generics market had total revenue of $69.3 billion in 2009, representing a compound annual growth rate (CAGR) of 10.3% for the period spanning 2005-2009.

The US OTC pharmaceuticals market generated total revenues of $27.5 billion in 2009, representing a compound annual growth rate (CAGR) of 3.4% for the period spanning 2005-2009.

The US pharmaceuticals market is expected to have total revenue of $292.8 billion in 2010, representing a compound annual growth rate (CAGR) of 2.9% for the period spanning 2006-2010.

Why you should buy this report

  • Spot future trends and developments
  • Inform your business decisions
  • Add weight to presentations and marketing materials
  • Save time carrying out entry-level research
  • BIOTECHNOLOGY IN THE UNITED STATES
    • Market Overview
    • Market Value
    • Market Segmentation I
    • Market Segmentation II
    • Five Forces Analysis
    • Market Forecasts
  • GENERICS IN THE UNITED STATES
    • Market Overview
    • Market Value
    • Market Volume
    • Market Segmentation II
    • Five Forces Analysis
    • Market Forecasts
  • OTC PHARMACEUTICALS IN THE UNITED STATES
    • Market Overview
    • Market Value
    • Market Segmentation I
    • Market Segmentation II
    • Market Share
    • Five Forces Analysis
    • Market Distribution
    • Market Forecasts
  • PHARMACEUTICALS IN THE UNITED STATES
    • Market Overview
    • Market Value
    • Market Segmentation I
    • Market Segmentation II
    • Market Share
    • Five Forces Analysis
    • Market Forecasts
  • MACROECONOMIC INDICATORS
  • APPENDIX
    • Data Research Methodology
    • About Datamonitor
    • Disclaimer
  • LIST OF TABLES
    • Table 1: United States biotechnology market value: $ billion, 2005-09
    • Table 2: United States biotechnology market segmentation I:% share, by value, 2009
    • Table 3: United States biotechnology Market Segmentation II: % share, by value, 2009
    • Table 4: United States biotechnology market value forecast: $ billion, 2009-14
    • Table 5: United States generics market value: $ billion, 2005-09
    • Table 6: United States generics market volume: volume penetration, 2005-09
    • Table 7: United States generics Market Segmentation II: % share, by value, 2009
    • Table 8: United States generics market value forecast: $ billion, 2009-14
    • Table 9: United States generics market volume forecast: volume penetration, 2009-14
    • Table 10: United States OTC pharmaceuticals market value: $ million, 2005-09
    • Table 11: United States OTC pharmaceuticals market segmentation I:% share, by value, 2009
    • Table 12: United States OTC pharmaceuticals Market Segmentation II: % share, by value, 2009
    • Table 13: United States OTC pharmaceuticals market share: % share, by value, 2009
    • Table 14: United States OTC pharmaceuticals market distribution: % share, by value, 2009
    • Table 15: United States OTC pharmaceuticals market value forecast: $ million, 2009-14
    • Table 16: United States pharmaceuticals market value: $ billion, 2006-10(e)
    • Table 17: United States pharmaceuticals market segmentation I:% share, by value, 2010(e)
    • Table 18: United States pharmaceuticals Market Segmentation II: % share, by value, 2010(e)
    • Table 19: United States pharmaceuticals market share: % share, by value, 2010(e)
    • Table 20: United States pharmaceuticals market value forecast: $ billion, 2010-15
    • Table 21: United States size of population (million), 2006-10
    • Table 22: United States GDP (constant 2000 prices, $ billion), 2006-10
    • Table 23: United States GDP (current prices, $ billion), 2006-10
    • Table 24: United States inflation, 2006-10
    • Table 25: United States consumer price index (absolute), 2006-10
    • Table 26: United States exchange rate, 2006-10
  • LIST OF FIGURES
    • Figure 1: United States biotechnology market value: $ billion, 2005-09
    • Figure 2: United States biotechnology market segmentation I:% share, by value, 2009
    • Figure 3: United States biotechnology Market Segmentation II: % share, by value, 2009
    • Figure 4: Forces driving competition in the biotechnology market in the United States, 2009
    • Figure 5: Drivers of buyer power in the biotechnology market in the United States, 2009
    • Figure 6: Drivers of supplier power in the biotechnology market in the United States, 2009
    • Figure 7: Factors influencing the likelihood of new entrants in the biotechnology market in the United States, 2009
    • Figure 8: Factors influencing the threat of substitutes in the biotechnology market in the United States, 2009
    • Figure 9: Drivers of degree of rivalry in the biotechnology market in the United States, 2009
    • Figure 10: United States biotechnology market value forecast: $ billion, 2009-14
    • Figure 11: United States generics market value: $ billion, 2005-09
    • Figure 12: United States generics market volume: volume penetration, 2005-09
    • Figure 13: United States generics Market Segmentation II: % share, by value, 2009
    • Figure 14: Forces driving competition in the generics market in the United States, 2009
    • Figure 15: Drivers of buyer power in the generics market in the United States, 2009
    • Figure 16: Drivers of supplier power in the generics market in the United States, 2009
    • Figure 17: Factors influencing the likelihood of new entrants in the generics market in the United States, 2009
    • Figure 18: Factors influencing the threat of substitutes in the generics market in the United States, 2009
    • Figure 19: Drivers of degree of rivalry in the generics market in the United States, 2009
    • Figure 20: United States generics market value forecast: $ billion, 2009-14
    • Figure 21: United States generics market volume forecast: volume penetration, 2009-14
    • Figure 22: United States OTC pharmaceuticals market value: $ million, 2005-09
    • Figure 23: United States OTC pharmaceuticals market segmentation I:% share, by value, 2009
    • Figure 24: United States OTC pharmaceuticals Market Segmentation II: % share, by value, 2009
    • Figure 25: United States OTC pharmaceuticals market share: % share, by value, 2009
    • Figure 26: Forces driving competition in the OTC pharmaceuticals market in the United States, 2009
    • Figure 27: Drivers of buyer power in the OTC pharmaceuticals market in the United States, 2009
    • Figure 28: Drivers of supplier power in the OTC pharmaceuticals market in the United States, 2009
    • Figure 29: Factors influencing the likelihood of new entrants in the OTC pharmaceuticals market in the United States, 2009
    • Figure 30: Factors influencing the threat of substitutes in the OTC pharmaceuticals market in the United States, 2009
    • Figure 31: Drivers of degree of rivalry in the OTC pharmaceuticals market in the United States, 2009
    • Figure 32: United States OTC pharmaceuticals market distribution: % share, by value, 2009
    • Figure 33: United States OTC pharmaceuticals market value forecast: $ million, 2009-14
    • Figure 34: United States pharmaceuticals market value: $ billion, 2006-10(e)
    • Figure 35: United States pharmaceuticals market segmentation I:% share, by value, 2010(e)
    • Figure 36: United States pharmaceuticals Market Segmentation II: % share, by value, 2010(e)
    • Figure 37: United States pharmaceuticals market share: % share, by value, 2010(e)
    • Figure 38: Forces driving competition in the pharmaceuticals market in the United States, 2010
    • Figure 39: Drivers of buyer power in the pharmaceuticals market in the United States, 2010
    • Figure 40: Drivers of supplier power in the pharmaceuticals market in the United States, 2010
    • Figure 41: Factors influencing the likelihood of new entrants in the pharmaceuticals market in the United States, 2010
    • Figure 42: Factors influencing the threat of substitutes in the pharmaceuticals market in the United States, 2010
    • Figure 43: Drivers of degree of rivalry in the pharmaceuticals market in the United States, 2010
    • Figure 44: United States pharmaceuticals market value forecast: $ billion, 2010-15
+44 20 8816 8548

Ask a question about United States: Pharmaceuticals Industry Guide

Enter the characters you see in the picture below
Captcha